This is the first study using PZP from proteomic profiling data to describe the upregulation of PZP in association with CVD markers, which supports the possibility that protein biomarkers may have clinical usefulness for discriminating CV risk in pediatric CKD [35,36]. The gene discussed is PZP; the disease is chronic kidney disease.